Hebert, A., Glaab, D. and Schreiber, R. 2019. A Phase 1 Open -Label Multicenter Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Calcipotriene Foam, 0.005% Applied Under Maximal Use Conditions in Adolescent Subjects with Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine. 3, 2 (Mar. 2019), 171. DOI:https://doi.org/10.25251/skin.3.2.11.